Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.

We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production...

Full description

Bibliographic Details
Main Authors: Milagros Griet, Graciela Font de Valdez, Carla L Gerez, Ana V Rodríguez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6034873?pdf=render
id doaj-bef16f75edfa4d73ac30cff0c8718b8c
record_format Article
spelling doaj-bef16f75edfa4d73ac30cff0c8718b8c2020-11-24T20:50:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01137e020042610.1371/journal.pone.0200426Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.Milagros GrietGraciela Font de ValdezCarla L GerezAna V RodríguezWe have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production, ii) LrS production, where the bacterial biomass was able to live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different factors on the growth and LrS production was performed. Biomass production was found to be dependent mainly on culture medium, while LrS production with anti-inflammatory activity depended on culture conditions of the biomass such as pH, agitation and growth phase. The L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for this work reduced the complete process cost by approximately 95%, respectively to laboratory scale cost.http://europepmc.org/articles/PMC6034873?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Milagros Griet
Graciela Font de Valdez
Carla L Gerez
Ana V Rodríguez
spellingShingle Milagros Griet
Graciela Font de Valdez
Carla L Gerez
Ana V Rodríguez
Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
PLoS ONE
author_facet Milagros Griet
Graciela Font de Valdez
Carla L Gerez
Ana V Rodríguez
author_sort Milagros Griet
title Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
title_short Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
title_full Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
title_fullStr Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
title_full_unstemmed Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098.
title_sort two-step production of anti-inflammatory soluble factor by lactobacillus reuteri crl 1098.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production, ii) LrS production, where the bacterial biomass was able to live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different factors on the growth and LrS production was performed. Biomass production was found to be dependent mainly on culture medium, while LrS production with anti-inflammatory activity depended on culture conditions of the biomass such as pH, agitation and growth phase. The L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for this work reduced the complete process cost by approximately 95%, respectively to laboratory scale cost.
url http://europepmc.org/articles/PMC6034873?pdf=render
work_keys_str_mv AT milagrosgriet twostepproductionofantiinflammatorysolublefactorbylactobacillusreutericrl1098
AT gracielafontdevaldez twostepproductionofantiinflammatorysolublefactorbylactobacillusreutericrl1098
AT carlalgerez twostepproductionofantiinflammatorysolublefactorbylactobacillusreutericrl1098
AT anavrodriguez twostepproductionofantiinflammatorysolublefactorbylactobacillusreutericrl1098
_version_ 1716803354615611392